The net sales for the quarter at Rs 301 crore were 7.75% higher against net sales of Rs 279 crore in the corresponding quarter in the previous year.
The company said its domestic formulation business recorded 12.52% YoY growth at Rs 129 crore, while the focus products group achieved growth of 16%.
The ebitda (earnings before interest, taxes, depreciation and amortisation) margin improved 525 basis points at 22.8% in Q1FY17, up from 17.55% in the previous year quarter.
At 02:18 pm, the stock was up 13% at Rs 353 on the BSE, as compared to 0.37% decline in the S&P BSE Sensex. The trading volumes on the counter jumped an over 15-fold with a combined 3.99 million shares changed on the BSE and NSE so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)